Form 4: C3.ai Senior VP Merel Witteveen Reports RSU Vesting and Tax-Related Stock Sale
Insider Transaction Report
C3.ai's Senior VP of Operations, Merel Witteveen, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.
Summary
- Merel Witteveen, Senior VP of Operations at C3.ai, Inc., reported transactions involving the company's Class A Common Stock.
- On June 7, 2025, 3,125 Restricted Stock Units (RSUs) vested, leading to the acquisition of 3,125 shares of Class A Common Stock.
- Following this acquisition, Merel Witteveen's direct beneficial ownership of Class A Common Stock increased to 10,935 shares.
- On June 9, 2025, 1,710 shares of Class A Common Stock were sold at a price of $26.23 per share.
- This sale was explicitly stated to be for covering tax obligations arising from the settlement of the vested RSUs.
- After the sale, Merel Witteveen's direct beneficial ownership of Class A Common Stock was 9,225 shares.
- The RSU award vests at a rate of 6.25% on the third month following July 6, 2022, and 6.25% quarterly thereafter, contingent on continued service.
- Merel Witteveen still holds 12,500 unvested Restricted Stock Units.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive as the reported transactions are routine insider equity compensation events, specifically the vesting of RSUs and a subsequent sale to cover tax obligations, which is a common and expected practice.
Positives
- The vesting of Restricted Stock Units (RSUs) indicates continued employment and alignment of executive incentives with long-term company performance.
- The sale of shares was specifically for covering tax obligations, which is a routine and expected event for equity compensation and does not signal a lack of confidence in the company.
Negatives
- The sale of 1,710 shares, even for tax purposes, results in a reduction of the insider's direct beneficial ownership in the company.
Future Outlook
The remaining 12,500 Restricted Stock Units held by Merel Witteveen are subject to a vesting schedule of 6.25% quarterly, contingent on continued service.
Management Comments
- Management indicated that the sale of 1,710 shares was specifically to cover tax obligations arising from the settlement of vested Restricted Stock Units.
Industry Context
This filing is a standard insider transaction report (Form 4) and does not provide information related to broader industry trends or competitive landscape, focusing solely on the equity movements of a specific executive.
Comparison to Industry Standards
- Not applicable, as this document is an insider transaction report (Form 4) and does not contain financial performance metrics or operational results for industry comparison.
Stakeholder Impact
- Minimal direct impact on shareholders as this is a routine insider transaction for tax purposes, not a discretionary sale indicating a lack of confidence.
- Employees with similar equity compensation plans may view this as a standard practice for managing vested equity.
Next Steps
- Continued vesting of remaining Restricted Stock Units according to the established quarterly schedule, contingent on Merel Witteveen's continued service.
Key Dates
| Date | Description |
|---|---|
| 07/06/2022 | Initial reference date for the RSU vesting schedule (6.25% vested on the third month following this date). |
| 06/07/2025 | Date of RSU vesting and acquisition of 3,125 Class A Common Stock. |
| 06/09/2025 | Date of sale of 1,710 Class A Common Stock to cover tax obligations. |
Recommendation
holdKeywords
C3.ai, AI, Merel Witteveen, Form 4, Insider Trading, Stock Sale, RSU, Restricted Stock Units, Equity Compensation, Tax Obligation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.